Finally, high DDX46 expression levels are significantly associated with shorter survival of CLL patients (S1 Fig) and thus, DDX46 can serve a marker of prognosis in these patients. This evidence concerns the gene DDX46 and B-cell chronic lymphocytic leukemia.